Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.

about

Serum lipid and glucose profiles in HIV-positive Nigerian children.

P2860

Q42334793-BA06B313-902F-4C27-B8A4-6002C0E7435E

P2860

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.

Item

http://www.wikidata.org/entity/Q36156655

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effectiveness and safety of ge ...... y in Cali-Colombia, 2011-2012.

@ast

Effectiveness and safety of ge ...... y in Cali-Colombia, 2011-2012.

@en

type

Item

label

Effectiveness and safety of ge ...... y in Cali-Colombia, 2011-2012.

@ast

Effectiveness and safety of ge ...... y in Cali-Colombia, 2011-2012.

@en

prefLabel

Effectiveness and safety of ge ...... y in Cali-Colombia, 2011-2012.

@ast

Effectiveness and safety of ge ...... y in Cali-Colombia, 2011-2012.

@en

P1476

Effectiveness and safety of ge ...... y in Cali-Colombia, 2011-2012.

@en

P2093

Jaime A Hincapié

http://www.w3.org/2001/XMLSchema#string

Jaime Galindo

http://www.w3.org/2001/XMLSchema#string

Sebastián González-Avendaño

http://www.w3.org/2001/XMLSchema#string

Ximena Galindo-Orrego

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of HIV-1 infection with early antiretroviral therapy

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Strategies for price reduction of HIV medicines under a monopoly situation in Brazil.

Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing.

P2888

s12879-016-1871-x

P304

532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-016-1871-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pedro Amariles

Héctor F Mueses-Marín

P577

2016-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046182900

http://www.w3.org/2001/XMLSchema#string

P698

27716093

http://www.w3.org/2001/XMLSchema#string

P932

5048459

http://www.w3.org/2001/XMLSchema#string

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.

about

P2860

P2860

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932